Is it time to draw the curtain on immune intervention trials in newly diagnosed patients with IDDM?
Drash
A L
AL
D002986:Clinical Trials as Topic; D016572:Cyclosporine / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D012107:Research Design; D017211:Treatment Failure
D007166:Immunosuppressive Agents; D016572:Cyclosporine